SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-18-003354
Filing Date
2018-04-30
Accepted
2018-04-30 16:37:31
Documents
57
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2235242z20-f.htm 20-F 2009352
2 EX-8.1 a2235242zex-8_1.htm EX-8.1 2214
3 EX-12.1 a2235242zex-12_1.htm EX-12.1 7822
4 EX-12.2 a2235242zex-12_2.htm EX-12.2 7820
5 EX-13.1 a2235242zex-13_1.htm EX-13.1 4669
6 EX-15.1 a2235242zex-15_1.htm EX-15.1 2744
  Complete submission text file 0001047469-18-003354.txt   10422810

Data Files

Seq Description Document Type Size
7 EX-101.INS fwp-20171231.xml EX-101.INS 2861855
8 EX-101.SCH fwp-20171231.xsd EX-101.SCH 90674
9 EX-101.CAL fwp-20171231_cal.xml EX-101.CAL 59825
10 EX-101.DEF fwp-20171231_def.xml EX-101.DEF 247035
11 EX-101.LAB fwp-20171231_lab.xml EX-101.LAB 645245
12 EX-101.PRE fwp-20171231_pre.xml EX-101.PRE 408296
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36686 | Film No.: 18790455
SIC: 2834 Pharmaceutical Preparations